1-3 of 3
Richard A. Newcomb
Close
Sort by
Journal Articles

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

Zachariah DeFilipp, Ashish V. Damania, Haesook T. Kim, Chia-Chi Chang, Areej El-Jawahri, Steven L. McAfee, AJ S. Bottoms, Vesselina Toncheva, Melissa M. Smith, Maria Dolaher, Lindsey Perry, Meghan White, Brittany Diana, Sheila Connolly, Bimalangshu R. Dey, Matthew J. Frigault, Richard A. Newcomb, Paul V. O’Donnell, Thomas R. Spitzer, Michael K. Mansour, Daniela Weber, Nadim J. Ajami, Elizabeth Hohmann, Robert R. Jenq, Yi-Bin Chen
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2074–2084.
https://doi.org/10.1182/bloodadvances.2024012556
Published: 2024
Includes: Supplemental data
Journal Articles

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy

P. Connor Johnson, Tejaswini Dhawale, Richard A. Newcomb, Hermioni L. Amonoo, Mitchell W. Lavoie, Dagny Vaughn, Kyle Karpinski, Areej El-Jawahri
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3541–3550.
https://doi.org/10.1182/bloodadvances.2022009117
Published: 2023
Includes: Supplemental data
Journal Articles

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation

Hermioni L. Amonoo, P. Connor Johnson, Ashley M. Nelson, Madison A. Clay, Elizabeth Daskalakis, Richard A. Newcomb, Emma C. Deary, Elizabeth F. Mattera, Daniel Yang, Katherine Cronin, Kofi Boateng, Stephanie J. Lee, Thomas W. LeBlanc, Areej El-Jawahri
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1108–1116.
https://doi.org/10.1182/bloodadvances.2022008281
Published: 2023